Helicobacter pylori antibiotic resistance in Iran

World Journal of Gastroenterology

Volumn 11, Issue 38, 2005, Pages 6009-6013

  Mohammadi, Marjan ^a   Doroud, Delaram ^a   Mohajerani, Nazanin ^a   Massarrat, Sadegh ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clarithromycin; H pylori; Iran; Metronidazole; Resistance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; RIBOSOME RNA; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DIFFUSION; GENE DELETION; GENE MUTATION; GENETIC DISORDER; HELICOBACTER PYLORI; IRAN; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE;

EID: 28644449599     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i38.6009     Document Type: Article

References (42)

1. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995; 7: 427-433
2. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A, Babaei M, Mosavi A, Mohagheghi MA. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 2003; 107: 113-118
3. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy. Aliment Pharmacol Ther 2001; 15: 1023-1029
4. Furuta T, Shirai N, Xiao F, El-Omar EM, Rabkin CS, Sugimura H, Ishizaki T, Ohashi K. Polymorphism of interleukin-1beta affect the eradication rates of Helicobacter pylori by triple therapy. Clin Gastroenterol Hepatol 2004; 2: 22-30
5. Gisbert JP, Pajares JM. Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis 2001; 19: 134-143
6. Grove DI, Koutsouridis G. Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting? Pathology 2002; 34: 71-73
7. Piana A, Are BM, Maida I, Dore MP, Sotgiu G, Realdi G, Mura I. Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains. New Microbiol 2002; 25: 123-130
8. Perri F, Qasim A, Marras L, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2003; 8: 53-60
9. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997; 41: 2621-2628
10. Versalovic JSD, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40: 477-480
11. Hao Q, Li Y, Zhang ZJ, Liu Y, Gao H. New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. World J Gastroenterol 2004; 1: 1075-1077
12. Chisholm SA, Owen RJ, Teare EL, Savarymuttu S. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol 2001; 39: 1217-1220
13. Occhialini AM, Urdaci M, Doucet-Populaire F, Bebear CM, Lamouliatte H, Megraud F. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997; 41: 2724-2728
14. Menard A, Santos A, Megraud F, Oleastero M. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002; 46: 1156-1157
15. Alarcon T, Domingo D, Prieto N, Lopez-Brea M. PCR using 3′-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol 2000; 38: 923-925
16. Marais A, Bilardi C, Cantet F, Mendz GL, Megraud F. Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori. Res Microbiol 2003; 154: 137-144
17. Chisholm SA, Owen RJ. Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori. J Med Microbiol 2004; 53: 135-140
18. Grignon B, Tankovic J, Megraud F, Glupczynski Y, Husson MO, Conroy MC, Emond JP, Loulergue J, Raymond J, Fauchere JL. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist 2002; 8: 61-66
19. Midolo PD, Turnidge J, Lambert JR. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Diagn Micr Infec Dis 1995; 21: 135-140
20. Eltahawy AT. Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi Teaching Hospital. Med Princ Pract 2002; 11: 65-68
21. McNulty C, Owen R, Tompkins D, Hawtin P, McColl K, Price A, Smith G, Teare L. Helicobacter pylori susceptibility testing by disc diffusion. J Antimicrob Chemother 2002; 49: 601-609
22. Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG, Vandenbroucke-Grauls CM. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother 1999; 43: 511-515
23. Chaves S, Gadanho M, Tenreiro R, Cabrita J. Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test. J Clin Microbiol 1999; 37: 1628-1631
24. Debets-Ossenkopp YJ, Pot RG, van Westerloo DJ, Goodwin A, Vandenbroucke-Grauls CM, Berg DE, Hoffman PS, Kusters JG. Insertion of mini-IS 605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637. Antimicrob Agents Chemother 1999; 43: 2657-2662
25. Van der Wouden EJ, de Jong A, Thijs JC, Kleibeuker JH, van Zwet AA. Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing. Antimicrob Agents Chemother 1999; 43: 1448-1456
26. Piccolomini R, Di Bonaventura G, Catamo G. Comparative evaluation of the E-test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997; 35: 1842-1846
27. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol 1993; 31: 1971-1974
28. Weiss K, Laverdiere M, Restieri C. Comparison of activity to 10 antibiotics against clinical strains of H pylori by three different techniques. Can J Gastroenterol 1998; 12: 181-185
29. Edwards DI. Nitroimidazole drugs-action and resistance mechanisms. II. Mechanisms of resistance. J Antimicrob Chemother 1993; 31: 9-20
30. Knapp CC, Ludwig MD, W JA. In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion. Antimicrob Agents Chemother 1991; 35: 1230-1231
31. Hachem CY, Clarridge JE, Reddy R, Flamm R, Evans DG, Tanaka SK, Graham DY. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996; 24: 37-41
32. Glupczynski Y, Broutet N, Cantagrel A, Andersen LP, Alarcon T, Lopez-Brea M, Megraud F. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2002; 21: 549-552
33. Parsons HK, Carter MJ, Sanders DS, Winstanley T, Lobo AJ. Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther 2001; 15: 1473-1478
34. Grignon B, Tankovic J, Megraud F, Glupczynski Y, Husson MO, Conroy MC, Emond JP, Loulergue J, Raymond J, Fauchere JL. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist 2002; 8: 61-66
35. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384
36. Yakoob J, Fan X, Hu G, Liu L, Zhang Z. Antibiotic susceptibility of Helicobacter pylori in the Chinese population. J Gastroenterol Hepatol 2001; 16: 981-985
37. Fakheri H, Malekzadeh RKM, Merat S, Fazel A, Alizadeh BZ, Massarrat S. Clarithromycin vs furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15: 411-416
38. Malekzadeh R, Merat S, Derakhshan MH, Siavoshi F, Yazdanbod A, Mikaeli J, Sotudemanesh R, Sotude M, Farahvash MJ, Nasseri-Moghaddam S, Pourshams A, Dolatshahi S, Abedi B, Babaei M, Arashi S, Majidpour A. Low Helicobacter pylori eradication rate with 4-7 d regimen in an Iranian population. J Gastroenterol Hepatol 2003; 18: 13-17
39. Roghani HS, Massarrat S, Pahlewanzadeh MR, Dashti M. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains. Eur J Gastroenterol Hepatol 1999; 11: 709-712
40. Bereswill S, Krainick C, Stahler F, Herrmann L, Kist M. Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxA mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori. FEMS Immunol Med Microbiol 2003; 36: 193-198
41. Dai N, Zhou G, Yan J. Correlation of rdxA gene mutation and metronidazole resistance of Helicobacter pylori. Zhejiang Daxue Xuebao Yixueban 2003; 32: 37-40
42. Yang YJ, Wu JJ, Sheu BS, Kao AW, Huang AH. The rdxA gene plays a more major role than frxA gene mutation in high-level metronidazole resistance of Helicobacter pylori in Taiwan. Helicobacter 2004; 9: 400-407